Interventional Oncology Market Size, Share & Industry Analysis, By Type (Radiation Therapy Devices, Ablation Devices {Microwave Ablation, Radiofrequency Ablation, Cryoablation, and Others}, and Embolization Devices {Microcatheters and Guidewires}, By Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, and Others), By End-user (Hospital, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Unit

Value (USD billion)

Growth Rate

CAGR of 8.1% from 2025-2032

Segmentation

By Type

• Radiation Therapy Devices
• Ablation Devices
  • Microwave ablation
  • Radiofrequency ablation
  • Cryoablation
  • Others
• Embolization Devices
  • Microcatheters
  • Guidewires

By Cancer Type

• Lung Cancer
• Liver Cancer
• Kidney Cancer
• Others

By End-User

• Hospitals
• Specialty Clinics
• Others

By Geography

• North America (By Type, Cancer Type, End-user, and Country)
  • U.S. (By Cancer Type)
  • Canada (By Cancer Type)
• Europe (By Type, Cancer Type, End-user, and Country/Sub-region)
  • U.K. (By Cancer Type)
  • Germany (By Cancer Type)
  • France (By Cancer Type)
  • Spain (By Cancer Type)
  • Italy (By Cancer Type)
  • Rest of Europe (By Cancer Type)
• Asia Pacific (By Type, Cancer Type, End-user, and Country/Sub-region)
  • Japan (By Cancer Type)
  • China (By Cancer Type)
  • India (By Cancer Type)
  • Australia (By Cancer Type)
  • Rest of Asia Pacific (By Cancer Type)
• Rest of the World (By Type, Cancer Type, and End-user)